Anavex Life Sciences Corp (AVXL)

[couldbebetter]

There is NO WAY this Brain Bleeding infused drug should be approved.
Yet, the news media makes it sound as if this is a promising therapy. No
doctor in their right mind would inflict this on their patents. How could you
give patients a treatment with horrific potential side effects for a negligible
benefit? Yet, Cramer this morning was suggesting that because the best
results were from those with early stage AD that perhaps the drug could
be started when patients were in their 40's. (Yet, BIIB stock gained
nearly $2 billion in market cap today.)